Design, Development and Therapy: First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of a Neuroprotective Poly (ADP‐ribose) Polymerase‐1 Inhibitor, JPI-289, in Healthy Volunteers - http://doi.org/10.2147/DDDT.S235802 #8
{{ message }}
